Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid—enrolled colon cancer patients?

Journal of Gastrointestinal Oncology

Kristie L. Foley¹  Heidi D. Klepin²  Eunyoung Song³  Alica S. Sparling⁴ 

[1] Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADivision of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADivision of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA;Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA;Department of Economics, Davidson College, Davidson, NC 28035, USADepartment of Economics, Davidson College, Davidson, NC 28035, USADepartment of Economics, Davidson College, Davidson, NC 28035, USA

关键词: Colonic neoplasms;    chemotherapy;    adjuvant;    health services accessibility;    chemotherapy;    socioeconomic factors;    Medicaid;   

DOI  :  10.21037/jgo.2016.02.01

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown